Suzhou Ribo Life Science Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2019	FY 2018
Period Ending	Apr '26 Apr 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Debt / Equity Ratio	20.55	20.55	-3.86	3.58	0.24	-
Net Debt / Equity Ratio	5.29	5.29	-2.19	1.72	-0.52	-0.44
Net Debt / EBITDA Ratio	-0.59	-0.59	-1.11	-0.53	1.33	1.10
Net Debt / FCF Ratio	-	-	-2.90	-0.61	1.12	0.94
Asset Turnover	0.20	0.20	0.21	-	-	-
Inventory Turnover	0.28	0.28	0.61	-	0.13	0.29
Quick Ratio	0.74	0.74	0.53	0.77	2.18	4.02
Current Ratio	0.86	0.86	0.65	0.94	2.55	4.71
Return on Equity (ROE)	-	-	-12091.58%	-	-48.77%	-41.96%
Return on Assets (ROA)	-23.42%	-23.42%	-23.62%	-	-25.04%	-26.12%
Return on Capital Employed (ROCE)	-117.20%	-117.20%	-109.20%	-108.80%	-43.60%	-46.00%
Buyback Yield / Dilution	-2.55%	-2.55%	-0.19%	-330.71%	-10.22%	-10.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.